z-logo
Premium
DIFFUSE LARGE B‐CELL LYMPHOMA: USING IMMUNE BIOMARKERS TO DEFINE NOVEL THERAPIES
Author(s) -
Zhao W.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.121_2629
Subject(s) - lymphoma , immune system , medicine , immunotherapy , germinal center , diffuse large b cell lymphoma , cancer research , myeloid , immunology , cancer , myeloid derived suppressor cell , b cell , antibody , suppressor

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here